Counterions-mediated gold nanorods-based sensor for label-free detection of poly(ADP-ribose) polymerase-1 activity and its inhibitor

被引:25
|
作者
Wu, Shuangshuang [1 ]
Wei, Min [2 ]
Yang, Haitang [1 ]
Fan, Jiahui [1 ]
Wei, Wei [1 ]
Zhang, Yuanjian [1 ]
Liu, Songqin [1 ]
机构
[1] Southeast Univ, Jiangsu Engn Lab Smart Carbon Rich Mat & Device, Jiangsu Prov Hi Tech Key Lab Bio Med Res, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China
[2] Henan Univ Technol, Coll Food Sci & Technol, Zhengzhou 450001, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Poly(ADP-ribose) polymerase; Nicotinamide adenine dinucleotide; Activated DNA; UV-vis spectrophotometer; Gold nanorod; Colorimetric method; PARP INHIBITORS; BREAST-CANCER; CELLS; ASSAY; IDENTIFICATION; BIOSENSOR; BINDING; AUTO;
D O I
10.1016/j.snb.2017.12.076
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Stable and sensitive detection of poly(ADP-ribose) polymerase-1 (PARP-1) is of great significance in many fields. Herein, a highly simple and sensitive colorimetric biosensor for label-free detection of PARP-1 based on counterions-induced gold nanorods (AuNRs) aggregation is put forward in this work. The specific DNA activated PARP-1 and resulted in the formation of electronegative poly(ADP-ribose) polymer (PAR) on the auto-modified domain of PARP-1 when nicotinamide adenine dinucleotide (NAD(+)) was used as substrate. Negative charged PAR induced the aggregation of CTAB-coated AuNRs which are employed as the colorimetric probe here, resulted in the obvious decrease of absorbance and the vivid color change. The aggregation process was visually observed by transmission electron microscope (TEM), and dark field measurements (DFM). By utilizing the change of longitudinal absorption and vivid color variation of AuNRs, PARP-1 can be detected in a linear range of 0.05-1.0 U with a detection limit of 0.006 U (0.261 ng), which is two orders of magnitude improved compared with previously reported colorimetric methods based on AuNPs. This detection method is label-free, visualized and reliable. The used AuNRs probe is stable and their synthesis procedures are simple. The method has been used to detect PARP-1 in ovarian cancer cells A2780, human breast cancer cells SK-BR-3 and MCF-7, obtained with satisfactory results. Besides, it has also been applied to evaluate the PARP-1 inhibitors, detect the change of PARP-1 activity in the presence of various DNA damages. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:565 / 572
页数:8
相关论文
共 50 条
  • [41] Binding Kinetics and Activity of Human Poly(ADP-ribose) Polymerase-1 on Oligo-Deoxyribonucleotide Substrates
    Jorgensen, Timothy J.
    Chen, Kevin
    Chasovskikh, Sergey
    Roy, Rabindra
    Dritschilo, Anatoly
    Uren, Aykut
    JOURNAL OF MOLECULAR RECOGNITION, 2009, 22 (06) : 446 - 452
  • [42] Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
    Daniel, Rachel A.
    Rozanska, Agata L.
    Thomas, Huw D.
    Mulligan, Evan A.
    Drew, Yvette
    Castelbuono, Deborah J.
    Hostomsky, Zdenek
    Plummer, E. Ruth
    Boddy, Alanv.
    Tweddle, Deborah A.
    Curtin, Nicola J.
    Clifford, Steven C.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1241 - 1249
  • [43] A key role for poly(ADP-Ribose) polymerase-1 activity during human dendritic cell maturation
    Aldinucci, Alessandra
    Gerlini, Gianni
    Fossati, Silvia
    Cipriani, Giulia
    Ballerini, Clara
    Biagioli, Tiziana
    Pimpinelli, Nicola
    Borgognoni, Lorenzo
    Massacesi, Luca
    Moroni, Flavio
    Chiarugi, Alberto
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 305 - 312
  • [44] Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors
    Ghabreau, L
    Roux, JP
    Frappart, PO
    Mathevet, P
    Patricot, LM
    Mokni, M
    Korbi, S
    Wang, ZQ
    Tong, WM
    Frappart, L
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 317 - 321
  • [45] Poly(ADP-ribose)polymerase-1 (PARP-1) expression and activity in primary human lung cells
    Ahmad, MH
    Torky, A
    Glahn, F
    Raemisch, A
    Foth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 113 - 113
  • [46] ATM-DEFICIENT GASTRIC CANCER CELLS ARE SENSITIVE TO THE POLY (ADP-RIBOSE) POLYMERASE-1 INHIBITOR, OLAPARIB
    Kubota, E.
    Lees-Miller, S. P.
    Bebb, D. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 37 - 37
  • [47] Adenosine Thiamine Triphosphate (AThTP) Inhibits Poly(ADP-Ribose) Polymerase-1 (PARP-1) Activity
    Tanaka, Takao
    Yamamoto, Daisuke
    Sato, Takaji
    Tanaka, Sunao
    Usui, Kazuya
    Manabe, Miki
    Aoki, Yui
    Iwashima, Yasuki
    Saito, Yoshihiro
    Mino, Yoshiki
    Deguchi, Hirofumi
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2011, 57 (02) : 192 - 196
  • [48] Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1α activity in neurons
    Lu, Ping
    Hogan-Cann, Adam D.
    Kamboj, Amit
    Chowdhury, Subir K. Roy
    Aghanoori, Mohamad-Reza
    Fernyhough, Paul
    Anderson, Christopher M.
    NEUROPHARMACOLOGY, 2019, 160
  • [49] Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines
    Nasuno, Tomomitsu
    Mimaki, Sachiyo
    Okamoto, Makito
    Esumi, Hiroyasu
    Tsuchihara, Katsuya
    CANCER SCIENCE, 2014, 105 (02) : 202 - 210
  • [50] Discovery of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor clinical candidate CEP-9722
    Hudkins, Robert L.
    Zulli, Allison L.
    Diebold, James L.
    Wells, Greg
    Aimone, Lisa D.
    Husten, Jean
    Miknyoczki, Sheila
    Ruggeri, Bruce A.
    Ator, Mark A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247